Re “Custom Gene-Editing Treatment Helps Baby in World’s First Case” (front page, May 16): Your article highlighting the remarkable work of Dr. Rebecca Ahrens-Nicklas in developing a bespoke ...
Hosted on MSN
Breakthrough: Gene Editing Jab Dramatically Lowers Harmful Cholesterol Levels In First Trial
It may sound unreal, but by just altering one gene could one day help many people to permanently lower their dangerously high cholesterol and blood fat levels. This is the biggest takeaway from the ...
Cardiovascular diseases could be among the world’s first medical conditions to be treated by changing a patient’s genes. If ongoing phase 3 trials succeed, gene editing will offer a novel therapy for ...
ARPA-H gene editing program THRIVE awards $160 million to seven research teams tasked with building scalable base-editing ...
Prime Medicine has come out ahead in its patent dispute with fellow gene editing biotech Beam Therapeutics, after a panel of ...
Urnov is a professor of molecular therapeutics at the University of California, Berkeley, and a director at its Innovative Genomics Institute. In May, news broke of a biomedical first: the on-demand ...
HCA Healthcare (NYSE:HCA) has published new research on gene-editing therapy for children with severe sickle cell disease and ...
What if you could precisely change the genome of a pre-implantation human embryo and then safely use that embryo to try to generate a healthier person? It’s a wild idea, but one that technology over ...
Volatile macroeconomic events are magnified in life science and healthcare applications, which are capital intensive, long-term investments with associated regulatory, safety, and commercial risks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results